Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Good
|
|
New words:
abandoned, Additionally, anecdotal, antit, auditor, bioreactor, branded, Cabilly, cancel, CAP, carcinoma, choose, College, comment, contest, contrary, correspondingly, coupon, dedicate, deducting, disrup, divert, DNA, double, ecall, es, exp, extinguish, flexibility, gefitinib, gemcitabine, grown, Hercepti, Huningue, idiopathic, IFR, ineffective, ion, ISS, litigatio, lus, mill, motivating, mparable, nomenclature, notification, Oceanside, oduct, onward, orporate, placebo, placement, pr, prejudice, quarte, rally, rank, recover, reexamination, Rheumatology, rust, sham, sNDA, tance, Treasury, udent, unsecured, unsubordinated, ur, vii, vision, vulnerability, week, wet, willincrease
Removed:
acceptance, alliance, amendment, authorized, began, Centocor, conduct, conflict, Congressional, cooperative, document, epidermal, European, extending, FOLFOX, granting, handling, improved, infringe, initial, institute, insufficient, legacy, low, maturing, minimize, NDA, North, offsetting, pivotal, positioned, practice, processing, progression, purest, rationale, recording, remove, repayment, Saltz, Serono, shareholder, site, spend, strength, strong, taxane, TCH, tion, treated, unrestricted, VIE, world
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.29 Purchase and Sale Agreement and Joint Escrow Instruction, Dated As of June 16, 2005, Between Genentech and Biogen Idec Inc.
- 15.1 Letter Regarding Unaudited Interim Financial Information.
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended.
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- PDF "Unofficial" PDF Copy of Q2 2005 Form 10-Q (June 30, 2005)
Related press release
Genentech similar filings
External links